Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I hear ya. And all those that read this board will know and reap the benefits!
So basically Teletrader.com copied the Seeking Alpha article and now, of course, is circulating more
poop. That's okay, since the doktor has set the record straight...
Now you have Teletrader.com posting on their website, some really inflammatory news and Vamkides (sp. wrong) has filed a new patent. Don't know if you have seen this but here we go...
http://www.teletrader.com/news/details/30997349?ts=1438546322138
oh yee of little faith
Nonetheless, we should post comments. An easy way to dole out relevant information to potential investors, don't you think?
This is where everyone needs to leave a comment below the SA article. You may not remember the SA article attack on ADXS in January, where Pearson, the writer, misinformed readers and the stock tanked like $5 in a matter of hours.
A number of well-informed readers posted comments and at the end of the week, the stock was back up to where it had been before the SA article.
Thanks again.
I think you're right.
Thank you for thinking ahead.
Thank you, RKmatters for clearing this up.
RK: Can you address this post?
You are aware that TPIV needs a blockade inhibitor. They will probably need a big pharma partner to provide it. That is not completely under their control.
After staying above $1 for more than 10 days, they have now gotten all they can out of the funding agreements... the conditional warrants. So they are funded, but their drugs are not going to be effective without blockade inhibitors. Glenn Wilson is aware of this and has stated this in his presentations.
Any comments?
yes, i must have missed it.
what you wrote is really confusing:
I just checked out the other thing that Neuronetix will be talking about at their sessions, a food supplement called Alpha Brain that supposedly increases cognition, according to studies. I read the reviews -- lots of negative ones, and the website looks like the typical "As Seen On TV" type site -- ugh.. I hope that AVXL is not going to be discounted because of the other company being a food supplement.
Post 7093 by Drano
Neuronetix is not Alpha Brain. Google it.
Some of us belong to a Google chat board through JBEM's posts and last night, a new investor to AVXL wrote something interesting that I thought everyone would like to read:
New investor here.
Yes I was taken aback and related the possibility of negative data this coming week as possibly being much the same as the ATHX situation.
The major difference however seems to be the adaptive nature of this open label AVXL trial while ATHX was not this kind of trial.
If I'm not mistaken, had ATHX adapted an open label adaptive trial, it could have controlled its trial parameters in terms of time of dosing better than being stuck to the time frame for administration to which it originally designed for the trial. I believe it presented at a big conference bc they believed they had good data when in fact the market interpreted it as the opposite in failing to meet its endpoints.
AVXL seems to played it smart in its trial design for sure which allows a robust model for efficacy.
Sumul
So in a really really roundabout way, you're saying through these documents that Harvey continues to advise Advaxis in all things immuno/onco. So sell your shares before it's too late.
let's look at more 11 year old documents for your amusement.
well they could have released that information earlier but chose to wait for a much more prolific event. that's all i'm saying...
it costs money and time to put out the right PR. Why not wait for a PR event that dwarfs a regular
PR notice??
thank you, tootalljones.
that's your side. what about when the pps goes up because of news. then a rising tide lifts all boats.
George can!
Can I also expect that you're 100% correct...
i'm just a person that believes in - don't spend money you don't have. i think tpiv is a quality stock but so what. we have seen its tumultuous existence and not for the squeamish. i have no time frame; however, 5000 shares at a dollar will return a profit according to blu and others within a year. what's wrong with that
gotta start somewhere and this board has it in spades for teaching the novice
if you can buy 5000 shares without going on margin - that should still give you a great profit.
just bought it. thank you.
thanks james. you and justice really came through during this great sack.
dawson
Just posted their 8K:
http://biz.yahoo.com/e/150611/tnxp8-k.html
I hope you're right; however, the market is rampant to sell on the news.
Are you holding or selling today?
Thank you for your insight and research.
and these comments too:
http://seekingalpha.com/news/2236746-advaxis-sell-off-continues
here's that critique I was telling you about:
https://docs.google.com/document/d/1lvAQVLOyGAFi-_xXrP-lAcRxjQuOGqz9b4CadGvcbuY/edit
Can you PM me your email address? If so, I can email you the five page critique by Justice.
Follow this person's research all the way back to Pearson:
http://finance.yahoo.com/mbview/userview/;_ylt=Ahyu24P5E0RSOsEffroeifHeAohG;_ylu=X3oDMTB1aGFpZ29oBHBvcwM3BHNlYwNNZWRpYU1zZ0JvYXJkc1hIUlVsdA--;_ylg=X3oDMTBhYWM1a2sxBGxhbmcDZW4tVVM-;_ylv=3?&u=justice_and_equality&bn=8276475a-7adf-3639-83af-4124e08449f5
He assumed way too much and was critical on way too little of the research. One extremely knowledgeable YMB ADXS poster, Justice, wrote a two page paper pointing out Pearson's deficiencies and ADXS's proficiencies.
This article came out in the beginning of January by a known shorter. If you read the comments below the article, you will see that Pearson was exposed for his shortcomings. The pps took a nosedive when the article was published and within a week rebounded completely. Pearson is no more and the stock is better than ever.
Cola had to say like. He took the high road.